Avalon GloboCare (ALBT) EBIT (2015 - 2026)

Avalon GloboCare has reported EBIT for 12 years, with the latest figure at -$2.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 52.41% year-over-year to -$2.7 million; the trailing twelve-month figure through Mar 2026 stood at -$8.5 million (down 47.07% YoY), and the FY2025 full-year result was -$7.6 million, down 56.81% from the prior year.
• EBIT for Q1 2026 stood at -$2.7 million, down from -$1.8 million in the prior quarter.
• The five-year high for EBIT was $8.4 million in Q4 2023, with the low at -$10.5 million in Q4 2022.
• Historically, EBIT has averaged -$1.8 million across 5 years, with a median of -$1.8 million in 2025.
• Annual changes were most pronounced in 2022 — EBIT sank 364.12% — and 2023, when it jumped 179.56%.
• Avalon GloboCare's EBIT stood at -$10.5 million in 2022, then jumped by 179.56% to $8.4 million in 2023, then tumbled by 114.65% to -$1.2 million in 2024, then plunged by 48.74% to -$1.8 million in 2025, then slumped by 49.48% to -$2.7 million in 2026.
• The last three EBIT figures came in at -$2.7 million (Q1 2026), -$1.8 million (Q4 2025), and -$76193.0 (Q3 2025), per Business Quant data.